Receptor Tyrosine Kinases Fall into Distinct Classes Based on Their Inferred Signaling Networks
Although many anticancer drugs that target receptor tyrosine kinases (RTKs) provide clinical benefit, their long-term use is limited by resistance that is often attributed to increased abundance or activation of another RTK that compensates for the inhibited receptor. To uncover common and unique fe...
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS),
2014-08-20T16:41:10Z.
|
| Subjects: | |
| Online Access: | Get fulltext |